One of the significant advantages of B Cell Engagers is their ability to redirect the patient's own T cells to target and kill cancer cells, bypassing the need for complex genetic manipulation. This approach can result in potent anti-tumor activity with a relatively straightforward manufacturing process. Additionally, because they are designed to specifically target cancer cells, they may offer a more favorable safety profile compared to traditional chemotherapy, which affects both cancerous and healthy cells.
